KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medpace Holdings (MEDP) EPS (Basic) (2016 - 2025)

Historic EPS (Basic) for Medpace Holdings (MEDP) over the last 11 years, with Q3 2025 value amounting to $3.95.

  • Medpace Holdings' EPS (Basic) rose 2700.96% to $3.95 in Q3 2025 from the same period last year, while for Sep 2025 it was $14.66, marking a year-over-year increase of 2392.22%. This contributed to the annual value of $13.06 for FY2024, which is 4198.73% up from last year.
  • Medpace Holdings' EPS (Basic) amounted to $3.95 in Q3 2025, which was up 2700.96% from $3.16 recorded in Q2 2025.
  • In the past 5 years, Medpace Holdings' EPS (Basic) registered a high of $3.95 during Q3 2025, and its lowest value of $1.11 during Q2 2021.
  • In the last 5 years, Medpace Holdings' EPS (Basic) had a median value of $2.3 in 2023 and averaged $2.41.
  • Within the past 5 years, the most significant YoY rise in Medpace Holdings' EPS (Basic) was 6323.53% (2021), while the steepest drop was 279.72% (2021).
  • Over the past 5 years, Medpace Holdings' EPS (Basic) (Quarter) stood at $1.39 in 2021, then surged by 56.83% to $2.18 in 2022, then grew by 16.97% to $2.55 in 2023, then skyrocketed by 48.24% to $3.78 in 2024, then rose by 4.5% to $3.95 in 2025.
  • Its EPS (Basic) stands at $3.95 for Q3 2025, versus $3.16 for Q2 2025 and $3.77 for Q1 2025.